LETTER
RNA viruses often require “cold chains” of transportation to prevent the breakdown of genetic material. The logistics of getting samples from the patient to a diagnostic laboratory, sometimes thousands of miles away from the original collection site, can be complex and resource intensive (1, 2). Nucleic acid degradation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA can compromise the accuracy of molecular detection methods. It has been demonstrated that nasopharyngeal specimens containing SARS-CoV-2 can be stored in phosphate-buffered saline (PBS) as a substitute for viral transport medium (VTM) for up to 7 days (3). Here, we evaluate the stability of differing viral loads of SARS-CoV-2 over 28 days stored at room temperature, 4°C, –20°C, or –80°C.
We used the first SARS-CoV-2-positive nasopharyngeal swab detected in our laboratory for spike-in material. PBS spiked with this SARS-CoV-2 specimen was stored in quadruplicates and divided into two concentrations, namely, 5,000 to 10,000 copies/ml (high titer) and 500 to 1,000 copies/ml (low titer), as determined by droplet digital reverse transcriptase PCR (RT-PCR). Nucleic acids were isolated on the Roche MagNA Pure96 system (Basel, Switzerland). Qualitative RT-PCR (qRT-PCR) was performed on 448 samples using our CDC-based laboratory-developed test, as described previously (4, 5).
For the high concentration of SARS-CoV-2, regardless of storage conditions, 100% of samples were detected by qRT-PCR through day 28. At room temperature, median cycle threshold (CT) values for lower titers for both N1 and N2 targets remained consistent through day 28, fluctuating less than 1 median CT (Table 1). For lower concentrations of virus, storage at room temperature was associated with reductions of positivity beginning at day 7, and by day 28, 0% of samples were detected for N1. Storage at room temperature was the least stable of all environmental conditions tested, with 54.2% of negative PCR results.
TABLE 1.
Storage condition by target and titer | Median CT value |
||||||
---|---|---|---|---|---|---|---|
Day 0 | Day 1 | Day 2 | Day 7 | Day 14 | Day 21 | Day 28 | |
N1 | |||||||
5,000–10,000 copies/ml | |||||||
Room temp | 31.4 | 31.0 | 31.5 | 31.2 | 31.6 | 31.4 | 31.3 |
4°C | 30.8 | 30.9 | 31.3 | 31.5 | 31.7 | 31.5 | 31.4 |
−20°C | 30.9 | 31.4 | 31.7 | 31.2 | 31.7 | 31.8 | 31.8 |
−80°C | 30.7 | 31.1 | 31.4 | 31.0 | 31.0 | 30.9 | 31.8 |
500–1,000 copies/ml | |||||||
Room temp | 33.4 | 36.8 | 36.3 | 36.1 (3/4)b | 35.8 (3/4) | 35.2 (1/4) | NDET (0/4) |
4°C | 34.4 | 34.9 | 35.1 | 35.9 | 35.9 | 35.8 (3/4) | 36.5 |
−20°C | 34.2 | 35.2 | 36.0 | 36.5 | 37.5 (1/4) | 37.4 | 37.3 (3/4) |
−80°C | 35.1 | 34.4 | 35.3 | 34.9 | 36.2 | 36.4 | 35.3 |
N2 | |||||||
5,000–10,000 copies/ml | |||||||
Room temp | 30.6 | 30.4 | 30.9 | 30.9 | 31.1 | 31.1 | 31.2 |
4°C | 30.4 | 30.2 | 30.5 | 30.6 | 31.3 | 30.6 | 31.1 |
−20°C | 30.6 | 30.5 | 30.9 | 30.6 | 31.6 | 30.9 | 31.2 |
−80°C | 30.6 | 30.5 | 30.6 | 30.6 | 30.6 | 30.5 | 31.2 |
500–1,000 copies/ml | |||||||
Room temp | 32.8 | 35.0 | 35.8 | 36.6 (3/4) | 37.0 | 38.3 (2/4) | 38.3 (3/4) |
4°C | 33.8 | 34.2 | 34.7 | 34.9 (3/4) | 36.0 | 35.4 | 36.4 |
−20°C | 33.7 | 35.3 | 36.0 | 37.8 (3/4) | 36.7 | 36.3 (3/4) | 37.0 (3/4) |
−80°C | 34.4 | 33.7 | 34.8 | 35.7 | 35.8 | 34.7 | 35.9 |
CT, cycle threshold; NDET, not detected. N1 and N2 are amplicons within the nucleocapsid gene of SARS-CoV-2.
Parentheticals denote the number of samples that were detected at a condition only if the 4 replicates were not all detected.
At 4°C, there was minimal change in CTs over time at the higher viral concentration. For lower titers, CTs increased by 2.1 CTs for N1 and 2.6 CTs for N2 over the 28 days. At –20°C, lower titers of virus fluctuated slightly more, increasing by ≥3 CTs. Storage of SARS-CoV-2 in PBS at –20°C was the second least stable condition, accounting for 37.5% of negative PCR results. Storage at –80°C showed the greatest stability, with all samples detected throughout the 28 days and ≤1.5 median CTs for both N1 and N2 targets.
Here, we show that the stability of SARS-CoV-2 can be maintained at 4°C for up to a month when –80°C storage is not available (6, 7). At viral loads of >5,000 copies/ml—corresponding to >75% of positive samples recovered in our clinical lab to date—different storage temperatures did not have a substantial impact on our ability to detect SARS-CoV-2 when stored in PBS.
REFERENCES
- 1.Nybo M, Cadamuro J, Cornes MP, Gómez Rioja R, Grankvist K. 2019. Sample transportation—an overview. Diagnosis (Berl) 26:39–43. doi: 10.1515/dx-2018-0051. [DOI] [PubMed] [Google Scholar]
- 2.Opitz L, Salinas-Riester G, Grade M, Jung K, Jo P, Emons G, Ghadimi BM, Beissbarth T, Gaedcke J. 2010. Impact of RNA degradation on gene expression profiling. BMC Med Genomics 3:36. doi: 10.1186/1755-8794-3-36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Rodino KG, Espy MJ, Buckwalter SP, Walchak RC, Germer JJ, Fernholz E, Boerger A, Schuetz AN, Yao JD, Binnicker MJ. 2020. Evaluation of saline, phosphate buffered saline and minimum essential medium as potential alternatives to viral transport media for SARS-CoV-2 testing. J Clin Microbiol doi: 10.1128/JCM.00590-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Lieberman JA, Pepper G, Naccache SN, Huang M-L, Jerome KR, Greninger AL. 2020. Comparison of commercially available and laboratory developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. J Clin Microbiol doi: 10.1128/JCM.00821-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Nalla AK, Casto AM, Huang M-L, Perchetti GA, Sampoleo R, Shrestha L, Wei Y, Zhu H, Jerome KR, Greninger AL. 2020. Comparative performance of SARS-CoV-2 detection assays using seven different primer/probe sets and one assay kit. J Clin Microbiol doi: 10.1128/JCM.00557-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Relova D, Rios L, Acevedo AM, Coronado L, Perera CL, Pérez LJ. 2018. Impact of RNA degradation on viral diagnosis: an understated but essential step for the successful establishment of a diagnosis network. Vet Sci 5:19. doi: 10.3390/vetsci5010019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ren S-Y, Wang W-B, Hao Y-G, Zhang H-R, Wang Z-C, Chen Y-L, Gao R-D. 2020. Stability and infectivity of coronaviruses in inanimate environments. World J Clin Cases 8:1391–1399. doi: 10.12998/wjcc.v8.i8.1391. [DOI] [PMC free article] [PubMed] [Google Scholar]